Hindered phenolic antioxidants are the primary defense against thermo-oxidative degradation in most commercial polymers, yet in many long-lived service environments, their effectiveness is limited less by radical-scavenging chemistry than by physical loss—migration into contact media, extraction by service fluids, and volatilization during processing. This review examines polymer-bound and macromolecular hindered phenols, in which the phenolic function is grafted onto preformed polymers, incorporated by copolymerization, multiplied in dendritic and hyperbranched architectures, or carried by hybrid and bio-based scaffolds. Each architecture family is analyzed against common criteria—structural control, phenolic hydroxyl content and retained activity, compatibility, and scalability—with study-level quantitative analysis of representative studies, selected for the completeness of their quantitative retention and performance data. Anti-migration mechanisms and the methods used to verify retention are critically assessed; in particular, survival of antioxidant activity after extraction is treated as evidence of functional retention, not as proof of covalent attachment, which requires independent structural characterization. Application performance is then reviewed across packaging, infrastructure, electrical insulation, elastomers, engineering plastics, biomedical polyethylene, and recycling. The strongest unmet needs are methodological: standardized extraction-based verification of covalent binding, quantification of phenol utilization efficiency in solid hosts, and long-term validation under sector-relevant protocols.
No takes yet. Share an insight, caveat, or question.
簡玉坤 et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: